Global Ocular Implant Market to Surpass US$ 20.2 Billion by 2026

News provided by

Jun 17, 2019, 09:06 ET

SEATTLE, June 17, 2019 /PRNewswire/ -- According to Coherent Market Insights, the global ocular implant market was valued at US$ 11,697.9 million in 2018, and is projected to exhibit a CAGR of 7.1% during the forecast period (2018 – 2026).

Key Trends and Analysis of the Global Ocular Implant Market:

Increasing product launches for different type ocular implants that are widely used in ophthalmic surgery to correct ophthalmic deformities is expected to drive global ocular implant market growth. For instance, in February 2019, EyePoint Pharmaceuticals, Inc. launched its YUTIQ in the U.S. YUTIQ is three-year intravitreal micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The product was approved by U.S. FDA in October 2018.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2699

Moreover, increasing number of research and development activities to develop innovative ocular implant is contributing to growth of global ocular implant market. For instance, in July 2018, Genentech, Inc. announced positive results for Phase II clinical trial study conducted to evaluate the safety and efficacy of the investigational Port Delivery System (PDS) with Ranibizumab, the first-ever eye implant to achieve sustained delivery of a biologic medicine, in people with wet age-related macular degeneration (AMD).

Furthermore, rising number of clinical studies to develop innovative ocular implants to be used in the treatment of ocular disorder such as glaucoma and corneal disease is expected to drive growth of the global ocular implant market. For instance, in July 2018, PolyActiva Pty Ltd initiated phase 1 clinical trial to determine and evaluate the safety, tolerability, and biodegradation of a prostaglandin (PA5108) ocular implant for treatment of open angle glaucoma. The study is estimated to complete in September 2019.

North America is expected to witness lucrative growth of ocular implant market, owing to growing initiatives by market players to establish its product portfolio in North American countries. For instance, in July 2018, Glaukos, based in San Clemente, California, received U.S. FDA approval for its iStent inject Trabecular Micro-Bypass System to launch in the U.S. The novel device is designed to treat mild to moderate primary open-angle glaucoma, is implanted alongside cataract surgeries to reduce intraocular pressure.

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/ocular-implant-market-2699

Key Market Takeaways:

The global ocular implant Market is projected to witness CAGR of XX% during the forecast period (2018 – 2026), owing to increasing product launches for ocular implants. In July 2018, Alcon launched its intraocular lens (IOL) portfolio including, Clareon AutonoMe IOL and delivery system, designed to provide easy and intuitive control during cataract surgery, at the Alcon-hosted Synergeyes clinical symposium in Sydney.
Among region, Asia Pacific is expected to show significant growth for ocular implant market, owing to increasing initiatives by key players involved in development of ophthalmic product. For instance, in May 2019, SIFI, the Italian developer of therapeutic solutions to treat ophthalmic disorders, and Zydus Cadila have been entered into strategic collaboration to market innovative IOLs and surgical products developed in Italy and licensed in India by SIFI.
Major players operating in the global ocular implant market include Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated., Morcher GmbH, OSD Medical GmbH, Ophtec BV, and ZEISS International.

Buy this exclusive business report now @ https://www.coherentmarketinsights.com/insight/buy-now/2699

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

SOURCE Coherent Market Insights